泰利塔西:针对自身免疫和类风湿性疾病的新视野
Liuting Zeng1, Kailin Yang2, Yang Wu3
1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Nanjing, China.
Journal of autoimmunity
|August 15, 2024
概括
一种新型的融合蛋白Telitacicept针对B细胞存活因子BLyS和APRIL,以潜在地治疗SLE和RA等自身免疫疾病. 临床研究正在进行中,以确认其有效性和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- B细胞激活因子 (BLyS) 和诱导增殖的甲基连接体 (APRIL) 促进B细胞的存活,有助于自身免疫性疾病,如系统性红斑狼 (SLE) 和类风湿性关节炎 (RA).
- 抑制BLyS和APRIL可以减少异常B细胞群和自身免疫疾病中的疾病活性.
研究的目的:
- 审查telitacicept的机理作用,药理动力学,疗效和安全性,telitacicept是一种针对自身免疫性疾病的双重向生物剂.
- 巩固从临床研究和telitacicept在RA和SLE治疗中的药理动力学分析的发现.
主要方法:
- 特利塔西塞普是一种TACI-Fc融合蛋白,旨在结合和中和BLyS和APRIL.
- 使用重组DNA技术将TACI和人类IgG Fc基因段合并.
- 整合了先前实验和药理动力学分析的数据.
主要成果:
- 德利塔西通过中和BLyS和APRIL来阻碍血细胞和成熟B细胞的成熟和生存.
- 目前正在进行的全球临床研究评估telitacicept在各种自身免疫性疾病中的有效性.
- 该审查整合了telitacicept的机理学,药理动力学,疗效和安全性数据.
结论:
- 泰利塔西是一种独特的治疗方法,可以同时针对BLyS和APRIL治疗自身免疫性疾病.
- 进一步的研究和临床试验至关重要,以确定telitacicept在治疗RA,SLE和其他自身免疫疾病中的作用.
- 这种双重向的融合蛋白显示出改善自身免疫性疾病治疗结果的潜力.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
T Cell Types and Functions
964
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Autoimmune Disorders
398
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
398
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


